ArticleFrontiers in oncology2025

Copy number gain of MET gene with low level in a metastatic lung adenocarcinoma patient represents response to salvage treatment with savolitinib and osimertinib: a case report.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.